Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms- |
Target |
Action stimulants |
Mechanism HER2 stimulants(Receptor tyrosine-protein kinase erbB-2 stimulants) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Adenocarcinoma of Lung | Clinical | China | 07 Sep 2020 | |
| Breast Cancer | Clinical | China | 07 Sep 2020 |





